The FDA-approved BRCA markers are specific genetic variants that have been validated by the Food and Drug Administration for use in genetic screening for breast and ovarian cancer risk. These markers are used to identify individuals who have a higher genetic predisposition to these cancers. The approved markers include variants such as rs386833395, rs80357906, and rs80359550. More markers have now been approved by the FDA for breast cancer risk reporting, which will be included in the report with the next update.